Results 1 to 10 of about 21,622 (232)

IPSS “bother question” score predicts health-related quality of life better than total IPSS score [PDF]

World Journal of Urology, 2022
The objective of this study was to investigate the role of bothersomeness of urinary symptoms on the general health-related quality of life (HRQoL) of patients with benign prostatic hyperplasia. We hypothesised that a higher International Prostate Symptom Score (IPSS) would be associated with a higher score on the IPSS bother question (IPSS-BQ), and a ...
Christian Beisland, Florin Vasile Hopland-Nechita   +1 more
exaly   +7 more sources

Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms

Hematology, 2022
Introduction Risk stratification is essential for treatment decision in myelodysplastic neoplasms (MDS). Molecular international prognostic scoring system (M-IPSS) has been recently developed combining somatic mutations and clinical information being ...
Theerin Lanamtieng, Chantana Polprasert, Ponlapat Rojnuckarin   +2 more
exaly   +4 more sources

VALIDATION OF INDONESIAN VERSION OF IPSS

Jurnal Urologi Indonesia, 2014
Objective: This study aims to validate the Indonesian version of International Prostate Symptom Score (IPSS)to ensure similar purpose and quality as the original version.
Richard Arie Monoarfa, Chaidir Arif Mochtar   +1 more
doaj   +3 more sources

Validation and comparison of the molecular international prognostic scoring system (IPSS-M) and the revised international prognostic scoring system (IPSS-R) in myelodysplastic neoplasms (MDS): a retrospective study

Hematology
Objectives To evaluate the prognostic value of the Molecular International Prognostic Scoring System (IPSS-M) compared to the Revised International Prognostic Scoring System (IPSS-R) in patients with myelodysplastic neoplasms (MDS) in the Jiangnan region
Baodong Ye, Qinghong Yu
exaly   +4 more sources

Aquablation/AquaBeam Waterjet Therapy for Benign Prostatic Hyperplasia: Three-Year Functional and Ejaculatory Outcomes in a Multicenter Real-World Italian Cohort. [PDF]

Low Urin Tract Symptoms
ABSTRACT Objective To evaluate the 3‐year functional outcomes of Aquablation/AquaBeam waterjet therapy for bladder outlet obstruction secondary to benign prostatic hyperplasia (BPH), with particular attention to urinary symptoms, quality of life, continence, ejaculatory function, and complications.
Porreca A, D'Agostino D, De Marchi D, Giampaoli M, Marino F, Busetto GM, Amodeo A, Corsi P, Claps F, Di Gianfrancesco L.   +9 more
europepmc   +2 more sources

The Four-Bladder Neck Implant Technique on Early Outcomes After Prostatic Urethral Lift: A Japanese Prospective Single-Center Study. [PDF]

Int J Urol
ABSTRACT Objectives Outcomes after prostatic urethral lift (PUL) may vary depending on implant position and bladder neck remodeling strategy. We evaluated the impact of bladder‐neck‐focused implant density using a four‐bladder neck implant technique on early postoperative urinary outcomes.
Anan G, Fujishima Y, Minami H, Ishii T, Kaga K.   +4 more
europepmc   +2 more sources

"Prognostic Significance of Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and Monocyte-to-Lymphocyte Ratios in Myeloid Neoplasms: A Systematic Review". [PDF]

Health Sci Rep
ABSTRACT Background and Aims Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are heterogeneous hematologic malignancies with variable outcomes. Inflammatory markers from routine blood counts, including neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), and monocyte‐to‐lymphocyte ratio (MLR), have emerged as ...
Dabir M, Abdolbaghaei A, Zoghi F, Karpasand F, Maleki A.   +4 more
europepmc   +2 more sources

IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons ≥ 60 years with myelodysplastic syndromes

Experimental Hematology & Oncology, 2022
There are considerable new data on mutation topography in persons with myelodysplastic syndromes (MDS). These data have been used to update conventional risk models such as the Revised International Prognostic Scoring System (IPSS-R).
Junying Wu, Yudi Zhang, Tiejun Qin, Zefeng Xu, Shiqiang Qu, Lijuan Pan, Bing Li, Yujiao Jia, Chengwen Li, Huijun Wang, Qingyan Gao, Wenyu Cai, Jingye Gong, Songyang Zhao, Fuhui Li, Robert Peter Gale, Zhijian Xiao   +16 more
doaj   +3 more sources

Overt-stage primary myelofibrosis after COVID-19 infection: a case report [PDF]

World Cancer Research Journal, 2022
OBJECTIVE: Primary Myelofibrosis (PMF) is an uncommon hematological condition where the bone marrow becomes progressively fibrotic, resulting in anemia, extramedullary hematopoiesis, and splenomegaly.
P. Darmada, N. Ustriyana, N. Kardinal, H. Saputra   +3 more
doaj   +1 more source

Outcome benefits to transurethral resection of the prostate in patients with benign prostatic hyperplasia at Medan regional hospital

JKKI (Jurnal Kedokteran dan Kesehatan Indonesia), 2021
Background: Benign prostatic hyperplasia (BPH) is a pathologic process that cause of lower urinary tract symptoms (LUTS) in aging men. Transurethral resection of the prostate (TURP) is still the current gold standard of BPH treatment.
Richman Patandung, Syah Mirsya Warli
doaj   +1 more source